Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience

Regular measurement of fibrinogen as dose guidance in catheter directed thrombolysis (CDT) for acute limb ischaemia (ALI) has recently been dropped from European guidelines based on inconsistent literature. This study aimed to determine whether low fibrinogen levels and high activated partial thromb...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of vascular and endovascular surgery 2023-03, Vol.65 (3), p.398-404
Hauptverfasser:	Doelare, Sabrina A.N., Oukrich, Safae, Ergin, Kübra, Jongkind, Vincent, Wiersema, Arno M., Lely, Rutger J., Ebben, Harm P., Yeung, Kak K., Hoksbergen, Arjan W.J.
Format:	Artikel
Sprache:	eng
Schlagworte:	APTT Arterial Occlusive Diseases - etiology Bleeding risk Catheter directed thrombolysis Clinical Decision-Making Fibrinogen Fibrinolytic Agents Hemorrhage - etiology Humans Ischemia - etiology Laboratory monitoring Peripheral arterial occlusions Peripheral Vascular Diseases - complications Prospective Studies Retrospective Studies Thrombolytic Therapy - adverse effects Tissue Plasminogen Activator Treatment Outcome Urokinase-Type Plasminogen Activator
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!